The New York Times – Business:
The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry and faces lower prices for its medicines under a deal with President Trump.
Author: RSS Feed
This post first appeared in The New York Times – Business. Read the original article.